Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04770272
Title Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy (neoMono)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Palleos Healthcare GmbH
Indications

triple-receptor negative breast cancer

Therapies

Atezolizumab + Carboplatin + Paclitaxel

Atezolizumab + Cyclophosphamide + Epirubicin

Atezolizumab

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.